Cibus (CBUS) to Post Earnings on Thursday

Cibus (NASDAQ:CBUS - Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, May 8th. Analysts expect Cibus to post earnings of ($0.66) per share and revenue of $1.15 million for the quarter.

Cibus (NASDAQ:CBUS - Get Free Report) last posted its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.19). The business had revenue of $1.21 million for the quarter, compared to the consensus estimate of $1.13 million. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. On average, analysts expect Cibus to post $-3 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Cibus Stock Down 3.4 %

NASDAQ:CBUS traded down $0.07 during trading hours on Tuesday, reaching $2.03. 18,381 shares of the company's stock were exchanged, compared to its average volume of 173,179. The company has a market capitalization of $66.65 million, a P/E ratio of -0.09 and a beta of 1.70. Cibus has a 12 month low of $1.40 and a 12 month high of $19.56. The business's 50-day simple moving average is $1.95 and its two-hundred day simple moving average is $2.86.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on CBUS shares. HC Wainwright reaffirmed a "buy" rating and set a $25.00 target price on shares of Cibus in a research report on Friday, March 21st. Canaccord Genuity Group dropped their target price on shares of Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Wednesday, January 22nd.

Hedge Funds Weigh In On Cibus

A hedge fund recently raised its stake in Cibus stock. Bank of America Corp DE boosted its position in shares of Cibus, Inc. (NASDAQ:CBUS - Free Report) by 113.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,536 shares of the company's stock after buying an additional 18,885 shares during the quarter. Bank of America Corp DE owned approximately 0.13% of Cibus worth $99,000 as of its most recent SEC filing. 33.81% of the stock is owned by hedge funds and other institutional investors.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.